Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 541–555 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2683
NPM1 Gene Mutation Test

This test detects mutations in the NPM1 gene, a significant marker for acute myeloid leukemia (AML) prognosis and treatment guidance.

Peripheral Blood or Bone Marrow Aspirate 2–3 Working Days 800.00 AED
View
View test specifications and preparation
What it measures
["NPM1 gene mutations", "Presence of specific genetic abnormalities in AML"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the lab about any anticoagulant therapy"]
Indications
["Diagnosis of acute myeloid leukemia (AML)", "Prognosis determination in AML", "Guiding targeted therapy in AML", "Risk stratification in AML"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81657-0 ICD-10: C92.00
Clinical summary
This test detects mutations in the NPM1 gene, a significant marker for acute myeloid leukemia (AML) prognosis and treatment guidance.
TEST-1292
NPM1 Mutation Analysis (Exon 12 Insertion) Test

This test detects the presence or absence of the NPM1 exon 12 insertion mutation in a patient's DNA, typically from bone marrow or peripheral blood.

Bone marrow or peripheral blood 7–8 Business Days 800.00 AED
View
View test specifications and preparation
What it measures
["NPM1 gene mutation", "Exon 12 insertion"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of acute myeloid leukemia (AML)", "Risk stratification in AML", "Minimal residual disease (MRD) monitoring in AML", "Personalized treatment planning for AML"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48766-0 ICD-10: C92.00
Clinical summary
This test detects the presence or absence of the NPM1 exon 12 insertion mutation in a patient's DNA, typically from bone marrow or peripheral blood.
TEST-1295
NPM1, FLT3, and CEBPA Gene Mutation Analysis Test

This test identifies specific mutations in the NPM1, FLT3, and CEBPA genes, which are key prognostic and therapeutic markers in acute myeloid leukemia (AML).

Peripheral Blood or Bone Marrow Aspirate 7–8 calendar days 2,600.00 AED
View
View test specifications and preparation
What it measures
["NPM1 gene mutations", "FLT3 gene mutations (ITD/TKD)", "CEBPA gene mutations"]
Parameters
[]
Preparation
["No special fasting or dietary preparation is required.", "A valid DHA-registered physician prescription must be provided."]
Indications
["Diagnosis and risk stratification of acute myeloid leukemia (AML)", "Selection of targeted therapies (e.g., tyrosine kinase inhibitors)", "Prognostic assessment in AML"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96934-8 ICD-10: C92.00
Clinical summary
This test identifies specific mutations in the NPM1, FLT3, and CEBPA genes, which are key prognostic and therapeutic markers in acute myeloid leukemia (AML).
TEST-1299
NPM1+ CEBPA Mutation Analysis Test

This test identifies somatic mutations in the NPM1 and CEBPA genes using Sanger sequencing.

Bone marrow aspirate or peripheral blood (EDTA) 7–8 business days 1,800.00 AED
View
View test specifications and preparation
What it measures
["Somatic mutations in NPM1 gene", "Somatic mutations in CEBPA gene"]
Parameters
[]
Preparation
["Valid doctor’s prescription required.", "No special fasting required.", "Immediate transport under cold-chain conditions is mandatory."]
Indications
["Diagnosis of Acute Myeloid Leukemia (AML)", "Prognostic stratification in AML", "Minimal residual disease (MRD) monitoring in AML"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79013-4 ICD-10: C92.0
Clinical summary
This test identifies somatic mutations in the NPM1 and CEBPA genes using Sanger sequencing.
TEST-2129
NRAS Gene Mutation Analysis for Hereditary Colorectal Cancer Test

This test evaluates the full coding region of the NRAS gene for pathogenic variants associated with hereditary colorectal cancer risk.

Peripheral Whole Blood (3–5 mL in EDTA tube) or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NRAS oncogene"]
Parameters
[{"name": "NRAS Gene Full Sequencing", "reference_range": null}]
Preparation
["No specific fasting required.", "Inform the lab of any medications being taken."]
Indications
["Hereditary CRC Risk Assessment", "Family Screening", "Targeted Therapy Guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93027-1 ICD-10: Z80.3
Clinical summary
This test evaluates the full coding region of the NRAS gene for pathogenic variants associated with hereditary colorectal cancer risk.
TEST-1962
NRAS Gene Sequencing (Exons 2‑3) Test

This test identifies mutations within exons 2 and 3 of the NRAS gene using next-generation sequencing.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spots (FTA Card) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NRAS gene mutations", "Single nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["Mandatory genetic counselling session", "Provide detailed three-generation family pedigree", "Obtain informed consent", "Provide complete current medication list"]
Indications
["Targeted cancer therapy guidance", "Hereditary cancer risk assessment", "Melanoma", "Colorectal adenocarcinoma"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 46035-3 ICD-10: Z15.09, Z13.71
Clinical summary
This test identifies mutations within exons 2 and 3 of the NRAS gene using next-generation sequencing.
TEST-1282
NRAS Mutation Analysis (Codons 12 & 13) Test

This test identifies activating mutations in the NRAS gene codons 12 and 13 within tumour tissue.

Fresh tumour tissue (biopsy) 7–8 working days 1,400.00 AED
View
View test specifications and preparation
What it measures
["NRAS gene mutations", "Codon 12 mutations", "Codon 13 mutations"]
Parameters
[]
Preparation
["Inform doctor of all anticoagulant use", "No fasting or special preparation needed"]
Indications
["Colorectal cancer", "Melanoma", "Thyroid carcinoma", "Haematological disorders", "Guidance for anti-EGFR therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 52050-0 ICD-10: C18.9
Clinical summary
This test identifies activating mutations in the NRAS gene codons 12 and 13 within tumour tissue.
TEST-1293
NTRK1 Gene Rearrangement Test

This test identifies NTRK1 gene fusions in tumor tissue using FISH.

Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block or Biopsy Slides 7–8 Business Days 1,200.00 AED
View
View test specifications and preparation
What it measures
["NTRK1 gene fusions", "Presence of NTRK1 rearrangements"]
Parameters
[]
Preparation
[]
Indications
["Patients with suspected or confirmed neoplasms where NTRK1 fusions are relevant", "Guiding targeted therapy with TRK inhibitors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94496-2 ICD-10: C80.1
Clinical summary
This test identifies NTRK1 gene fusions in tumor tissue using FISH.
TEST-1274
NTRK1, NTRK2, NTRK3 Gene Fusion Panel (Pan‑TRK FISH) Test

This diagnostic test evaluates solid tumour tissue for the presence of NTRK1, NTRK2, or NTRK3 gene fusions using Fluorescence In-Situ Hybridization (FISH).

Archival Tissue Specimen (Formalin‑Fixed Paraffin‑Embedded Tumour Blocks / Slides) 7–8 working days 3,600.00 AED
View
View test specifications and preparation
What it measures
["NTRK1 gene fusions", "NTRK2 gene fusions", "NTRK3 gene fusions"]
Parameters
[]
Preparation
["A valid DHA-licensed physician’s prescription is mandatory.", "Provide formalin-fixed paraffin-embedded (FFPE) tumour tissue blocks or slides.", "Inform the lab about any current medications or blood thinners."]
Indications
["Identification of NTRK gene fusions in solid tumours", "Determining eligibility for targeted therapies (e.g., larotrectinib, entrectinib)", "Guiding precision oncology treatment decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95524-0 ICD-10: Z01.84
Clinical summary
This diagnostic test evaluates solid tumour tissue for the presence of NTRK1, NTRK2, or NTRK3 gene fusions using Fluorescence In-Situ Hybridization (FISH).
TEST-1278
NTRK2 Gene Fusion FISH Test

This test identifies NTRK2 gene rearrangements in tumor tissue using Fluorescence In-Situ Hybridization (FISH). It helps determine eligibility for targeted TRK inhibitor therapy.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block 7–8 working days 1,200.00 AED
View
View test specifications and preparation
What it measures
["NTRK2 gene rearrangement", "Gene fusion status"]
Parameters
[]
Preparation
[]
Indications
["Identification of NTRK2 gene fusions in tumor tissue", "Guiding targeted therapy with TRK inhibitors", "Precision oncology for NTRK-fusion-positive cancers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92898-6 ICD-10: Z01.818
Clinical summary
This test identifies NTRK2 gene rearrangements in tumor tissue using Fluorescence In-Situ Hybridization (FISH). It helps determine eligibility for targeted TRK inhibitor therapy.
TEST-1288
NTRK3 Gene Rearrangement Test

This diagnostic test evaluates for the presence of rearrangements or fusions involving the NTRK3 gene within tumor tissue using Fluorescence In Situ Hybridization (FISH).

Formalin-fixed paraffin-embedded (FFPE) tumor tissue blocks or fresh tissue in approved transport medium 7–8 business days 1,200.00 AED
View
View test specifications and preparation
What it measures
["NTRK3 gene rearrangements", "Oncogenic fusions"]
Parameters
[]
Preparation
[]
Indications
["Personalized cancer care", "Oncology", "Pediatric tumors", "Precision medicine", "Guiding targeted therapy with TRK inhibitors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86553-5 ICD-10: C80.1
Clinical summary
This diagnostic test evaluates for the presence of rearrangements or fusions involving the NTRK3 gene within tumor tissue using Fluorescence In Situ Hybridization (FISH).
TEST-1283
NUDT15 Gene Mutation Analysis Test

This test identifies genetic variants in the NUDT15 gene that affect thiopurine metabolism.

Peripheral Blood 12 working days 1,000.00 AED
View
View test specifications and preparation
What it measures
["NUDT15 gene variants (e.g., R139C)", "Thiopurine metabolism risk"]
Parameters
[]
Preparation
[]
Indications
["Patients starting azathioprine or 6-mercaptopurine", "Autoimmune conditions", "Oncologic conditions", "Gynecologic conditions", "Asian or Middle Eastern populations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94803-7 ICD-10: Z13.89
Clinical summary
This test identifies genetic variants in the NUDT15 gene that affect thiopurine metabolism.
TEST-2736
Nx Gen Sequencing: Maturity Onset Diabetes of the Young (MODY) Test

This test identifies genetic mutations associated with Maturity Onset Diabetes of the Young (MODY).

Whole blood (EDTA tube) – Peripheral blood 30 working days 3,100.00 AED
View
View test specifications and preparation
What it measures
["Genetic mutations in MODY-associated genes", "Copy number variants in MODY-associated genes"]
Parameters
[]
Preparation
["Fasting is not required", "No specific medication or diet restrictions"]
Indications
["Suspected monogenic diabetes", "Early-onset diabetes", "Family history suggestive of MODY", "Need for precise diabetes classification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92893-3 ICD-10: E13.8
Clinical summary
This test identifies genetic mutations associated with Maturity Onset Diabetes of the Young (MODY).
TEST-2718
NxGen Sequencing: Comprehensive Epilepsy Test

This test evaluates the entire coding region of the genome (exome) to detect genetic variants associated with epilepsy.

Peripheral Whole Blood 40 Working Days 2,600.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in coding regions of the genome", "Genetic etiology of epilepsy disorders"]
Parameters
[]
Preparation
["No specific fasting required", "Continue prescribed anti-epileptic medication unless advised otherwise by your physician"]
Indications
["Diagnosis of epilepsy with unclear etiology", "Genetic risk assessment for epilepsy", "Guiding personalized treatment strategies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G40.9
Clinical summary
This test evaluates the entire coding region of the genome (exome) to detect genetic variants associated with epilepsy.
TEST-1271
Oncomine Breast cfTNA Assay (NGS) Test

This test evaluates circulating tumor nucleic acids (cfTNA) in plasma to identify genomic alterations associated with breast cancer.

10 mL peripheral whole blood (liquid biopsy) 14–21 calendar days 7,000.00 AED
View
View test specifications and preparation
What it measures
["Circulating tumor nucleic acids (cfTNA)", "Genomic alterations (e.g., mutations, copy number variations)"]
Parameters
[]
Preparation
[]
Indications
["Guiding targeted therapy selection in breast cancer", "Monitoring treatment response", "Detecting resistance mechanisms", "Longitudinal monitoring of clonal evolution"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88040-1 ICD-10: C50.919
Clinical summary
This test evaluates circulating tumor nucleic acids (cfTNA) in plasma to identify genomic alterations associated with breast cancer.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area